1、Specialising in the commercialisationof intellectual propertyFrontier IP Group PlcAnnual Report&Financial StatementsYear ended 30 June 2013 FRONTIER IP GROUP PLC 1 ANNUAL REPORT AND FINANCIAL STATEMENTS For the year ended 30 June 2013 CONTENTS Page Key Points 2 Chairmans Statement 3 Business Review
2、5 Directors 12 Advisers 13 Directors Report 14 Directors Remuneration Report 17 Independent Auditors Report 19 Consolidated Statement of Comprehensive Income 21 Consolidated Statement of Financial Position 22 Company Statement of Financial Position 23 Consolidated and Company Statements of Changes i
3、n Equity 24 Consolidated and Company Statements of Cash Flows 25 Accounting Policies 26 Notes to the Financial Statements 30 Five Year Record 40 FRONTIER IP GROUP PLC 2 Key Points Encouraging progress over the year Portfolio companies:three new spin-out companies added Nandi Proteins secured licence
4、 agreement with Tate&Lyle University partnerships:first licensing contribution and first equity stake from Plymouth University partnership Fund management operations:collaboration agreement signed with the University of Dundee to exploit commercial drug development opportunities MOU signed for energ
5、y sector collaboration with Iberdrola and Narec Capital Revenue from services increased to 174,000(2012:162,000)Total revenue reduced to 117,000(2012:223,000)reflecting an unrealised loss on the revaluation of investments of 57,000(2012:unrealised profit of 61,000)Loss before tax reduced to 368,000(
6、2012:loss of 380,000)Loss per share reduced to 3.5p(2012:loss of 5.5p)Cash balances at 30 June 2013 of 155,000 (2012:44,000)Net assets per share as at 30 June 2013 of 21.1p(2012:36.0p)Post year-end share placing raised 392,000(gross)Board remains encouraged about prospects for further progress with